Biological risks including sea lice infestations, algae blooms, infectious salmon anemia (ISA), and warming ocean temperatures affecting survival rates and growth performance
Regulatory tightening on production licenses, biomass limits, and environmental standards (particularly in Norway and British Columbia) limiting growth potential
Long-term shift toward land-based recirculating aquaculture systems (RAS) by competitors, potentially offering lower biological risk and proximity to consumption markets
Climate change impacts on ocean temperatures, salinity, and extreme weather events affecting sea-based farming viability
Oversupply from Norwegian producers (Mowi, SalMar, Lerøy) and Chilean farmers expanding capacity, depressing global salmon prices
Competition from lower-cost protein sources (chicken, pangasius, tilapia) and plant-based seafood alternatives in retail channels
Consolidation among larger competitors with superior scale economies, processing capabilities, and market access
Vertical integration by retailers developing direct sourcing relationships with larger producers, bypassing mid-sized farmers
High leverage (Debt/Equity 1.35) combined with negative operating margins creates refinancing risk if salmon prices remain depressed
Severe liquidity constraints (Current Ratio 0.44) with negative free cash flow (-$0.9B) requiring continued access to capital markets
Large ongoing capex commitments ($1.3B TTM) for capacity expansion that may not generate returns if biological performance doesn't improve
Working capital intensity of biological assets (live salmon inventory) which can lose value rapidly during disease outbreaks or price crashes
StructuralCompetitiveBalance Sheet